Terphogz varieties soon available in Germany, Australia and New Zealand

The Australian company ECS Botanics has secured an exclusive partnership with the California-based breeder Terphogz to grow and sell its cannabis flowers in Germany, Australia, and New Zealand.

The eight-year agreement allows ECS Botanics to work on Terphogz’s strains, including the strain The Original Z (formerly Zkittlez), in these emerging cannabis markets.

While the B2B (business-to-business) model will be the preferred approach for the German market, Australia will see the launch of a direct-to-consumer channel. A suitable distribution model for New Zealand is still under evaluation.

Smell the rainbow!

By forming a partnership with ECS Botanics, Terphogz is leveraging its expertise in cultivation, its GMP-certified facilities but above all its global reach, which will enable it to offer European and Australian patients access to cannabis genetics that were previously exclusive to the California market medical and recreational—at least in its legal form.

Nan-Maree Schoerie, CEO of ECS Botanics, expressed her enthusiasm for this partnership. According to her, the collaboration with Terphogz enables ECS Botanics to introduce high-quality medical cannabis with unique terpene profiles for patients in’Germany, d’Australia and New Zealand. In particular, she mentioned the importance of recent regulatory changes in Germany, which will enable ECS to introduce Terphogz products to patients across the country.

«We are delighted to partner with Terphogz to bring The Original Z and other unique Terphogz products to the global market,» said Ms. Schoerie. «This partnership enables ECS to provide patients in Germany, Australia, and New Zealand with access to high-quality medical cannabis featuring Z’s unique terpene profiles and associated therapeutic benefits.»

The Power of Terphogz Genetics

Terphogz, known for its unique genetics and the importance it places on organic farming, has built a solid reputation in California. Its genetic database includes some of the most sought-after varieties in the world, the’Original Z being particularly well-known for her profile terpenic distinct and its therapeutic benefits. The breeder/grower’s focus on cultivating cannabis using living soil and organic methods aligns well with ECS Botanics’ approach.

Jon Orantes, CEO of Terphogz, welcomed this new partnership, highlighting the values shared by both companies. He commended ECS Botanics for its commitment to organic farming, which meets the standards that Terphogz patients and enthusiasts have come to expect.

«We are delighted to have found an organic partner in ECS that also farms organically according to the strictest standards, using living soil—just as our patients and followers expect from us in the United States,» said Mr. Orantes.

The timing of this partnership is crucial, as the regulatory landscapes in countries such as Germany continue to evolve. With Germany being one of the largest markets in the medical marijuana In Europe, the launch of the Terphogz product line is expected to meet the growing demand for high-quality cannabis products, particularly those that offer therapeutic benefits combined with a high terpene content.

Similarly, the ‘Australia has experienced significant growth In the medical cannabis sector, an increasing number of patients are turning to cannabis to relieve various conditions. Thanks to ECS Botanics’ local presence and its established customer base, Terphogz products are likely to find a receptive audience.

Expansion into New Zealand, which is still only in the planning stages, represents an opportunity to tap into another market emerging cannabis. The exact distribution model within the country is still under discussion, but thanks to ECS Botanics’ capabilities, patients should soon have access to Terphogz strains.